As France's leading biocluster, Genopole is an incubator for cutting-edge projects in biotechnology. Located in the city of Évry, just south of Paris, Genopole provides a unique environment for scientists and entrepreneurs seeking to advance research and innovation.

Discover >


Genopole accompanies researchers, postdocs and start-up entrepreneurs through all the phases of their projects to ensure the best possible conditions for business development.

Discover >

Genopole’s citizens

Every day, at Genopole, researchers, entrepreneurs and students cross paths, share ideas and unite forces in a veritable melting pot for innovation.

Discover >


Giving wings to research and empowering employment in our community are cornerstones of Genopole's mission. Catch up on recent scientific advances, the accomplishments of our biotech actors and the events that enliven the biocluster.

Discover >

Innovate with us

Discover >


Pépinière Genopole Entreprises – 4, rue Pierre Fontaine – Genopole Campus 3
91058 EVRY Cedex – FRANCE
Phone: +33 1 60 87 89 80

Thierry JEAN : CEO – PhD
Web Site >
Xentech - Genopole Company Xentech - Genopole Company

#R&D Services and Products

  • Oncology
  • Preclinical expertise
  • Predictive models
  • Biomarkers
  • Companion tests
  • New therapeutic targets
  • Patient-derived tumor xenografts

Field of Activity

XenTech is an innovative biotech company specialized in the preclinical evaluation of cancer drugs and the identification of biomarkers and therapeutic targets.


XenTech was founded in 2006 by researchers from the Institut Curie having over 15 years of experience in preclinical pharmacology in oncology. This spin-off company dedicated to biomarker discovery and preclinical evaluation of anticancer therapies is known worldwide for its expertise in the field of patient-derived tumor xenografts (PDX).
Located on the Genopole Campus, its experimental models are housed at the CERFE.


XenTech develops an innovative experimental platform based on one of the world’s largest collections of patient derived tumors xenografts (PDX). The collection is representative of the major types of cancer (breast, lung, colon, prostate) but also includes less common tumors (melanoma, ovarian cancer, renal cancer, pancreatic cancer, glioma, hepatoblastoma).
XenTech’s platform is of considerable value for translational research in oncology, notably for drug screening and the identification of biomarkers useful for precision oncology.
XenTech participates in the development of novel cancer therapies by offering its services, models and expertise in preclinical oncology to stakeholders in oncology research.


  • Partnership with the world’s biggest pharmaceutical companies involved in oncology.
  • Partnerships with major Cancer Centers.
  • Member of the ITCC-P4 consortium, a European IMI2 project to develop a platform for pediatric cancer models


  • Collaborative partnership with the pharmaceutical industry on drug response biomarkers and new therapeutic targets discovery programs.
  • Collaborative partnership with hospital structures to pursue development of the preclinical platform.
  • Research fee-for-service contracts with pharmaceutical companies, biotechs and academic groups for evaluating antitumor efficacy of their drug candidates.
  • Further Information

    Annual turnover: €3M
    32 staff members

    A unique panel of breast cancers preclinical models.
    World-renowned experimental platform and scientific expertise.

    An experimental platform and scientific expertise recognized worldwide.
    A network of partners and customers extended internationally.

Genopole’s Companies

#R&D Services and Products

In same field

Alt Biotech - Genopole's Company Gene.iO#3

Alt Biotech

Alt Biotech offers an innovative bioproduction platform for non-therapeutic recombinant proteins: productive, scalable, with low environmental impact

Quibiotic - Projet Shaker


Quibiotic develops three molecular synthesis platforms aimed at innovatively modifying β-lactam rings for new anti-infectives.

Maison M - Startup génopolitaine

Maison M

Personalized and sustainable Cosmetic House inspired by various and unique beauties. The innovative Maison M lipstick delivers any shade customized by its user.

Adlin - Entreprise génopolitaine - #IA Biotech

Adlin Science

ADLIN Science is a mission-driven company that strives to transform the life sciences sector by providing solutions to bring together public actors (institutes, hospitals, universities) and private actors (biotechs, pharma). Our innovative approach is to develop the first decentralized Digital Research Environment (fundamental, translational, and clinical) dedicated to the entire public and private ecosystem. ADLIN is the scientific trusted third-party among all actors in the sector with the ambition to accelerate innovation in healthcare while participating in research financing.

Altar - entreprise génopolitaine - intégre le groupe Ginko Bioworks


Ginkgo Bioworks is a specialist in the conception and operation of automated fluidic continuous culture systems for adaptive laboratory evolution and the development of microbial strains for industry.

Polytheragene - Genopole's Company


Manufacture and sale of new high performance transfecting agents for gene therapy, high-throughput screening and biomanufacturing. Cosmetic and therapeutic molecules from plant biomass.

Phinc Development - Genopole's Company

PhinC Development

PhinC Development brings its expertise to small and mid-sized biotechs and pharmaceutical companies looking to advance their early-stage drug research.

New england Biolabs - Genopole's Compny - 50 Years logo

New England Biolabs France

New England Biolabs is a private company manufacturing reagents for the life science industry particularly focused on products for genomic research.

Hybrigenics - Genopole's company

Hybrigenics Services

Hybrigenics Services proposes fee-for-services R&D support and provides innovative technological platforms for i) protein interaction studies (protein-protein, drug-protein, mechanisms of action) and ii) selection and validation of VHH antibodies.

logo abcell Bio - Genopole's Companie


Abcell-bio is a laboratory specializing in the isolation of human hematopoietic stem cells and primary cells derived from perinatal tissue and cord blood.

View all >
With the support from
Région île de France